Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 23.00
+0.49 (2.18%)
At close: Jul 24, 2025, 2:57 PM CST
Jiangsu CoWin Biotech Revenue
Jiangsu CoWin Biotech had revenue of 43.01M CNY in the quarter ending March 31, 2025, with 49.31% growth. This brings the company's revenue in the last twelve months to 140.08M, up 13.70% year-over-year. In the year 2024, Jiangsu CoWin Biotech had annual revenue of 125.88M, down -26.54%.
Revenue (ttm)
140.08M
Revenue Growth
+13.70%
P/S Ratio
18.05
Revenue / Employee
168.16K
Employees
833
Market Cap
2.53B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |